Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Condensed Consolidated Statements of Operations
Grant and award revenue	$ 1,159	$ 2,973	$ 3,819	$ 3,939
Operating expenses
Research and development	5,824	9,485	17,647	25,975
General and administrative	3,111	3,244	8,983	9,861
Total operating expenses	8,935	12,729	26,630	35,836
Operating loss	(7,776)	(9,756)	(22,811)	(31,897)
Other income (expense)
Interest income	90	294	257	567
Interest expense	(4,346)	(2,923)	(11,756)	(7,462)
Change in fair value of the Convertible Loan	(14,643)	6,904	(15,191)	17,276
Total other income (expense), net	(18,899)	4,275	(26,690)	10,381
Net loss	$ (26,675)	$ (5,481)	$ (49,501)	$ (21,516)
Per share information:
Net loss per share, basic	$ (0.74)	$ (0.15)	$ (1.37)	$ (0.6)
Weighted average shares outstanding, basic	36,226,285	36,180,124	36,201,674	36,153,388
Net loss per share, diluted	$ (0.74)	$ (0.15)	$ (1.37)	$ (0.6)
Weighted average shares outstanding, diluted	36,226,285	36,180,124	36,201,674	36,153,388